Top Clinical Trials companies in Denmark by Free Cash Flow Yield

This ranking features the top 17 Clinical Trials companies in Denmark ranked by Free Cash Flow Yield, averaging a Free Cash Flow Yield of -0.10%, for July 05, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Clinical Trials company in Denmark has the highest Free Cash Flow Yield ?

The Clinical Trials company in Denmark with the highest Free Cash Flow Yield is Saniona AB (publ) (Stockholm Stock Exchange: SANION.ST) at 15.63%.

Which Clinical Trials company in Denmark has the lowest Free Cash Flow Yield ?

The Clinical Trials company in Denmark with the lowest Free Cash Flow Yield is IO Biotech, Inc. (NasdaqGS: IOBT) at None.

What are the top 10 Clinical Trials companies in Denmark by Free Cash Flow Yield ?

The top 10 Clinical Trials companies in Denmark by Free Cash Flow Yield are Saniona AB (publ), Genmab A/S, H. Lundbeck A/S, Novo Nordisk A/S, Danish Aerospace Company A/S, Bavarian Nordic A/S, ChemoMetec A/S, ALK-Abelló A/S, Gubra A/S and Zealand Pharma A/S.

What are the bottom 10 Clinical Trials companies in Denmark by Free Cash Flow Yield ?

The bottom 10 Clinical Trials companies in Denmark by Free Cash Flow Yield are IO Biotech, Inc., Initiator Pharma A/S, Ascendis Pharma A/S, 2cureX AB (publ), ViroGates A/S, BioPorto A/S, FluoGuide A/S, Zealand Pharma A/S, Gubra A/S and ALK-Abelló A/S.